Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients

Brain

Volumn 126, Issue 6, 2003, Pages 1300-1318

  Hammers, Alexander ^a,b,c   Koepp, Matthias J ^a,b,c   Richardson, Mark P ^a,b,c   Hurlemann, René ^b,c   Brooks, David J ^a   Duncan, John S ^b,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Frontal lobe epilepsy; Localization related epilepsy; Occipital lobe epilepsy; Parietal lobe epilepsy; SPM99

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CARBAMAZEPINE; CARBON 11; CLOBAZAM; FLUMAZENIL; GABAPENTIN; LAMOTRIGINE; NEUROTRANSMITTER; OXCARBAZEPINE; PHENYTOIN; REMACEMIDE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DRUG BINDING; EPILEPSY; FEMALE; FRONTAL LOBE EPILEPSY; GRAND MAL EPILEPSY; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIMPLE PARTIAL SEIZURE; WHITE MATTER;

ADOLESCENT; ADULT; ARTIFACTS; EPILEPSIES, PARTIAL; EPILEPSY, FRONTAL LOBE; FALSE NEGATIVE REACTIONS; FEMALE; FLUMAZENIL; GABA MODULATORS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0037677601     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg138     Document Type: Article

References (76)

1. Ashbumer J, Friston KJ. Multimodal image coregistration and partitioning - a unified framework. Neuroimage 1997; 6: 209-17.
2. Ashbumer J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999; 7: 254-66.
3. Bailey DL. 3D acquisition and reconstruction in positron emission tomography. Ann Nucl Med 1992; 6: 121-30.
4. Berkovic SF, McIntosh AM, Kalnins RM, Jackson GD, Fabinyi GC, Brazenor GA, et al. Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology 1995; 45: 1358-63.
5. A receptor subunit expression and function in temporal lobe epilepsy. Nat Med 1998; 4: 1166-72.
6. Chevassus-au-Louis N, Congar P, Represa A, Ben-Ari Y, Gaiarsa J-L. Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci USA 1998; 95: 10263-8.
7. Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990; 27: 406-13.
8. Commission on Neuroimaging of the International League Against Epilepsy. Guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery. Epilepsia 1998; 39: 1375-6.
9. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993; 13: 15-23.
10. 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 1997; 62: 141-50.
11. Desbiens R, Berkovic SF, Dubeau F, Andermann F, Laxer KD, Harvey S, et al. Life-threatening focal status epilepticus due to occult cortical dysplasia. Arch Neurol 1993; 50: 695-700.
12. Dubeau F, Tampieri D, Lee N, Andermann E, Carpenter S, Leblanc R, et al. Periventricular and subcortical nodular heterotopia. A study of 33 patients. Brain 1995; 118: 1273-87.
13. Duncan JS. Imaging and epilepsy. Brain 1997; 120: 339-77.
14. Emery JA, Roper SN, Rojiani AM. White matter neuronal heterotopia in temporal lobe epilepsy: a morphometric and immunohistochemical study. J Neuropathol Exp Neurol 1997; 56: 1276-82.
15. Francione S, Kahane P, Tassi L, Hoffmann D, Durisotti C, Pasquier B, et al. Stereo-EEG of interictal and ictal electrical activity of a histologically proved heterotopic gray matter associated with partial epilepsy. Electroencephalogr Clin Neurophysiol 1994; 90: 284-90.
16. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990; 10: 458-66.
17. Friston KJ, Frith CD, Liddle PF, Frackowiak RS. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991; 11: 690-9.
18. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RS. Spatial registration and normalization of images. Hum Brain Mapp 1995a; 3: 165-189.
19. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995b; 2: 189-210.
20. Grootoonk S. Dual energy window correction for scattered photons in 3D positron emission tomography [PhD thesis]. Guildford (UK): University of Surrey; 1995.
21. 11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001a; 56: 897-906.
22. Hammers A, Koepp MJ, Richardson MP, Labbé C, Brooks DJ, Cunningham VJ, et al. Central benzodiazepine receptors in malformations of cortical development. A quantitative study. Brain 2001b; 124: 1555-65.
23. Hammers A, Koepp MJ, Free SL, Brett M, Richardson MP, Labbé C, et al. Implementation and application of a brain template for multiple volumes of interest. Hum Brain Mapp 2002a; 15: 165-74.
24. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 2002b; 125: 2257-71.
25. Hand KS, Baird VH, Van Paesschen W, Koepp MJ, Revesz T, Thom M, et al. Central benzodiazepine receptor autoradiography in hippocampal sclerosis. Br J Pharmacolol 1997; 122: 358-64.
26. Hannan AJ, Servotte S, Katsnelson A, Sisodiya S, Blakemore C, Squier M, et al. Characterization of nodular neuronal heterotopia in children. Brain 1999; 122: 219-38.
27. Hardiman O, Burke T, Phillips J, Murphy S, O'Moore B, Staunton H, et al. Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy. Neurology 1988; 38: 1041-7.
28. Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993; 43: 1998-2006.
29. Jack CR Jr, Sharbrough FW, Cascino GD, Hirschorn KA, O'Brien PC, Marsh WR. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992; 31: 138-146.
30. Juhász C, Chugani DC, Muzik O, Shah A, Shah J, Watson C, et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 2001; 56: 1650-1658.
31. Kasper BS, Stefan H, Buchfelder M, Paulus W. Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol 1999; 58: 22-8.
32. Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 1996; 119: 1677-1687.
33. Koepp MJ, Labbé C, Richardson MP, Brooks DJ, Van Paesschen W, Cunningham VJ, et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997a; 120: 1865-1876.
34. Koepp MJ, Richardson MP, Labbé C, Brooks DJ, Cunningham VJ, Ashburner J, et al. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology 1997b; 49: 764-773.
35. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000; 54: 332-9.
36. 11C] flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11: 735-744.
37. Kuzniecky RI, Jackson GD. Developmental disorders. In: Engel JJ Jr, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven; 1997. p. 2517-32.
38. Kuzniecky R, Garcia JH, Faught E, Morawetz RB. Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol 1991; 29: 293-8.
39. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-9.
40. 11C]flumazenil: application of the steady state principle. In: Uemura K, Lasson NA, Jones T, Kanno I, editors. Quantification of brain function. Tracer kinetics and image analysis in brain PET. Amsterdam: Elsevier Science; 1993. p. 303-11.
41. 11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy. Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 2000; 54: 2252-60.
42. Li LM, Dubeau F, Andermann F, Fish DR, Watson C, Cascino GD, et al. Periventricular nodular heterotopia and intractable temporal lobe epilepsy: poor outcome after temporal lobe resection. Ann Neurol 1997; 41: 662-8.
43. Loup F, Wieser HG, Yonekawa Y, Aguzzi A, Fritschy JM. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 2000; 20: 5401-5419.
44. Lyon G, Gastaut M. Considerations on the significance attributed to unusual cerebral histological findings recently described in eight patients with primary generalized epilepsy. Epilepsia 1985; 26: 365-367.
45. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995; 45: 1391-5.
46. 11C]methyl-6-oxo-4H-imidazo[1,5-a][1, 4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot 1984; 35: 973-6.
47. Meencke HJ, Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984; 25: 8-21.
48. Meencke HJ, Janz D. The significance of microdysgenesia in primary generalized epilepsy: an answer to the considerations of Lyon and Gastaut. Epilepsia 1985; 26: 368-71.
49. Muzik O, da Silva EA, Juhász C, Chugani DC, Shah J, Nagy F, et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000; 54: 171-9.
50. Nagy F, Chugani DC, Juhász C, da Silva EA, Muzik O, Kupsky W, et al. Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex. J Cereb Blood Flow Metab 1999; 19: 939-47.
51. A receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system. J Chem Neuroanat 1990; 3: 59-76.
52. Palmini A, Gambardella A, Andermann F, Dubeau F, da Costa JC, Olivier A, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995; 37: 476-87.
53. Pinard J-M, Feydy A, Carlier R, Perez N, Pierot L, Burnod Y. Functional MRI in double cortex: functionality of heterotopia. Neurology 2000; 54: 1531-3.
54. Raymond AA, Fish DR, Stevens JM, Sisodiya SM, Alsanjari N, Shorvon SD. Subependymal heterotopia: a distinct neuronal migration disorder associated with epilepsy. J Neurol Neurosurg Psychiatry 1994; 57: 1195-202.
55. Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryo-plastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995; 118: 629-60.
56. 11C-flumazenil PET study. Ann Neurol 1996; 40: 188-198.
57. Richardson MP, Friston KJ, Sisodiya SM, Koepp MJ, Ashburner J, Free SL, et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain 1997; 120: 1961-73.
58. Richardson MP, Koepp MJ, Brooks DJ, Coull JT, Grasby P, Fish DR, et al. Cerebral activation in malformations of cortical development. Brain 1998a; 121: 1295-304.
59. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998b; 51: 485-492.
60. Rojiani AM, Emery JA, Anderson KJ, Massey JK. Distribution of heterotopic neurons in normal hemispheric white matter: a morphometric analysis. J Neuropathol Exp Neurol 1996; 55: 178-83.
61. Rugg-Gunn FJ, Eriksson SH, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain 2001; 124: 627-36.
62. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 1998; 121: 2067-81.
63. Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988; 2: 863-6.
64. 11C-flumazenil and 18F-FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993; 56: 615-21.
65. Savic I, Thorell JO, Roland P. [11C]flumazenil positron emission tomography visualises frontal epileptogenic regions. Epilepsia 1995; 36: 1225-32.
66. Sisodiya SM. Surgery for malformations of cortical development causing epilepsy. Brain 2000; 123: 1075-91.
67. Sisodiya SM, Free SL, Thom M, Everitt AE, Fish DR, Shorvon SD. Evidence for nodular epileptogenicity and gender differences in periventricular nodular heterotopia. Neurology 1999; 52: 336-41.
68. A receptor subunits in the hippocampus of the rat after kainic acid-induced seizures. Epilepsy Res 1998; 32: 129-39.
69. Spreer J, Martin P, Greenlee MW, Wohlfarth R, Hammen A, Arnold SM, et al. Functional MRI in patients with band heterotopia. Neuroimage 2001; 14: 357-65.
70. Szelies B, Weber-Luxenburger G, Pawlik G, Kessler J, Holthoff V, Mielke R, et al. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 1996; 3: 109-18.
71. Talairach J, Toumoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme; 1988.
72. Thom M, Sisodiya SM, Harkness WF, Scaravilli F. Microdysgenesis in temporal lobe epilepsy: a quantitative and immunohistochemical study of white matter neurones. Brain 2001; 124: 2299-309.
73. Van Paesschen W, Connelly A, King MD, Jackson GD, Duncan JS. The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study. Ann Neurol 1997; 41: 41-51.
74. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-46.
75. Worsley KJ, Evans AC, Marrett S, Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992; 12: 900-18.
76. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996; 4: 58-73.